ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2024

[Efficacy and safety of gilteritinib-based combination therapy bridging allo-HSCT in relapsed or refractory acute myeloid leukemia patients with positive FLT3-ITD mutation].

Y Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.